BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12680769)

  • 1. Structural and functional analysis of caspase active sites.
    Chéreau D; Kodandapani L; Tomaselli KJ; Spada AP; Wu JC
    Biochemistry; 2003 Apr; 42(14):4151-60. PubMed ID: 12680769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
    Fang B; Boross PI; Tozser J; Weber IT
    J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
    Agniswamy J; Fang B; Weber IT
    FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modeling of nematode Caenorhabditis elegans CED3 protein-inhibitor complex.
    Azim MK; Grossmann JG; Zaidi ZH
    Biochem Biophys Res Commun; 2001 Feb; 281(1):115-21. PubMed ID: 11178968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
    Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
    Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.
    Becker JW; Rotonda J; Soisson SM; Aspiotis R; Bayly C; Francoeur S; Gallant M; Garcia-Calvo M; Giroux A; Grimm E; Han Y; McKay D; Nicholson DW; Peterson E; Renaud J; Roy S; Thornberry N; Zamboni R
    J Med Chem; 2004 May; 47(10):2466-74. PubMed ID: 15115390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
    Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
    J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity.
    Piana S; Sulpizi M; Rothlisberger U
    Biochemistry; 2003 Jul; 42(29):8720-8. PubMed ID: 12873132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
    Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
    Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
    Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
    Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaSPredictor: a new computer-based tool for caspase substrate prediction.
    Garay-Malpartida HM; Occhiucci JM; Alves J; Belizário JE
    Bioinformatics; 2005 Jun; 21 Suppl 1():i169-76. PubMed ID: 15961454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational restrictions in the active site of unliganded human caspase-3.
    Ni CZ; Li C; Wu JC; Spada AP; Ely KR
    J Mol Recognit; 2003; 16(3):121-4. PubMed ID: 12833566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement of 3D models of horseradish peroxidase isoenzyme C: predictions of 2D NMR assignments and substrate binding sites.
    Zhao D; Gilfoyle DJ; Smith AT; Loew GH
    Proteins; 1996 Oct; 26(2):204-16. PubMed ID: 8916228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-15 is autoprocessed at two sites that contain an aspartate residue in the P1' position.
    Eckhart L; Kittel C; Ballaun C; Tschachler E
    Biochem Biophys Res Commun; 2006 Dec; 350(4):955-9. PubMed ID: 17045244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
    Goode DR; Sharma AK; Hergenrother PJ
    Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant caspase specificity by competitive substrates.
    Benkova B; Lozanov V; Ivanov IP; Mitev V
    Anal Biochem; 2009 Nov; 394(1):68-74. PubMed ID: 19595985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex.
    Xu G; Cirilli M; Huang Y; Rich RL; Myszka DG; Wu H
    Nature; 2001 Mar; 410(6827):494-7. PubMed ID: 11260720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary patterns of retinal-binding pockets of type I rhodopsins and their functions.
    Adamian L; Ouyang Z; Tseng YY; Liang J
    Photochem Photobiol; 2006; 82(6):1426-35. PubMed ID: 16922602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
    Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
    J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.